New Long-Term Lease Agreements, Acquisitions, Financial Results and Stock Updates - Analyst Notes on Ventas, Duke Realty, BioMed Realty, MFA and Retail Properties of America

NEW YORK, May 19, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Ventas, Inc. (NYSE: VTR), Duke Realty Corp. (NYSE: DRE), BioMed Realty Trust Inc. (NYSE: BMR), MFA Financial, Inc. (NYSE: MFA) and Retail Properties of America, Inc. (NYSE: RPAI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2619-100free.

Ventas, Inc. Analyst Notes
On May 14, 2014, Ventas, Inc.'s (Ventas) stock went up by 0.71%, closing at $67.09 per share. Over the past three trading days, however, the Company's stock has declined nearly 1% compared to the Dow Jones Industrial Average which has on the contrary gained 0.18% during the same three day trading period. The full analyst notes on Ventas are available to download free of charge at:

http://www.analystsreview.com/2619-VTR-19May2014.pdf

Duke Realty Corp. Analyst Notes
On May 14, 2014, Duke Realty Corp.'s (Duke Realty) stock increased by 0.81%, ending the day at $17.45 per share. Over the previous five days, the Company's stock has lost 0.51% compared to the S&P 500 which has gained 0.55% during the same duration of time. The full analyst notes on Duke Realty are available to download free of charge at:

http://www.analystsreview.com/2619-DRE-19May2014.pdf

BioMed Realty Trust Inc. Analyst Notes
On May 8, 2014, BioMed Realty Trust Inc. (BioMed Realty) announced that it has signed a new long-term lease with Intertek USA, Inc., a division of Intertek Group plc., for 46,142 square feet at the Company's Wateridge Summit property in San Diego, California. According to the Company, the term of the new lease with Intertek is approximately eleven years., Alan Gold, Chairman and CEO of BioMed Realty, stated, "We are very pleased to welcome Intertek Pharmaceutical Services to Wateridge Summit. The leasing success at our Wateridge Summit facilities in such short order is a testament to the expertise and strong relationships of our San Diego team, but it also reflects the strength of the biotechnology market in San Diego which continues to innovate, invest capital and grow. We look forward to serving the real estate needs of Chetan's team in Sorrento Mesa to propel their research forward." The full analyst notes on BioMed Realty are available to download free of charge at:

http://www.analystsreview.com/2619-BMR-19May2014.pdf

MFA Financial, Inc. Analyst Notes
On May 1, 2014, MFA Financial, Inc. (MFA) reported its Q1 2014 financial results. The Company's quarterly net income attributable to shareholders stood at $72.4 million or $0.20 per diluted share, compared to Q1 2013 net income attributable to shareholders of $75.3 million or $0.21 per diluted share. Commenting on the results, MFA's CEO, William Gorin, stated, "In the first quarter, MFA continued to generate consistent and attractive results in an investment environment characterized by very low short-term interest rates. MFA remains positioned for a more flexible monetary policy by the Federal Reserve based on measures of the labor markets, core inflation and other incoming data. Due to our strategy of investment across the residential mortgage asset universe, we were able to increase the yield on MFA's interest earning assets during the quarter to 4.32% while also reducing estimated effective duration, a measure of MFA's interest rate sensitivity, to 0.83. Leverage, which reflects the ratio of our financing obligations to equity, remained at 2.9:1." The full analyst notes on MFA are available to download free of charge at:

http://www.analystsreview.com/2619-MFA-19May2014.pdf

Retail Properties of America, Inc. Analyst Notes
On May 5, 2014, Retail Properties of America, Inc. (Retail Properties of America) announced that it has entered into an agreement to acquire six multi-tenant retail assets through the dissolution of its MS Inland joint venture. According to the Company, it will acquire its partner's 80% ownership interest in the six properties. Additionally, Retail Properties of America stated that the properties have an agreed upon value of $292.5 million, with its partner's 80% interest valued at $234.0 million. The Company will also assume the joint venture's $142.2 million of in-place mortgage financing, as of March 31, 2014, at a weighted average interest rate of 4.79%, closing on June 2014, subject to customary closing conditions. Retail Properties of America President and CEO, Steve Grimes, stated, "We are very pleased to add these outstanding assets to our wholly-owned portfolio. This transaction will enhance our presence in our target markets with high quality multi-tenant retail assets demonstrating strong demographic profiles and long-term growth potential. Additionally, this transaction further simplifies our balance sheet, as we will have no remaining investment property unconsolidated joint ventures." The full analyst notes on Retail Properties of America are available to download free of charge at:

http://www.analystsreview.com/2619-RPAI-19May2014.pdf

About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.

EDITOR'S NOTES:

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review